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Abstract 
 
Aims: To assess the probability of individuals with early-diagnosed hip or knee osteoarthritis 
experiencing a fall and/or fracture compared to a cohort without osteoarthritis. 
 
Methods: Data were analysed from the Osteoarthritis Initiative dataset. We identified all 
people who were diagnosed with hip or knee osteoarthritis within a 12 month period, compared 
to those without osteoarthritis. We determined whether there was a difference in the occurrence 
of falls, with or without a consequential fractures, between people newly diagnosed with hip or 
knee osteoarthritis compared to those who had not using odd ratios (OR) and 95% confidence 
intervals.  
 
Results: 552 individuals with hip osteoarthritis were compared to 4244 individuals without hip 
osteoarthritis. 1350 individuals with knee osteoarthritis were compared to 3445 individuals 
without knee osteoarthritis. People with knee osteoarthritis had a 54% greater chance of 
experiencing a fall compared to those without (OR: 1.54; 95% CI: 1.35 to 1.77). People with 
hip osteoarthritis had a 52% greater chance of experiencing a fall compared to those without 
hip osteoarthritis (OR: 1.52; 95% CI: 1.26 to 1.84). People with knee and hip osteoarthritis 
demonstrated over an 80% greater chance of experiencing a fracture in the first 12 months of 
their diagnosis compared to those without hip or knee osteoarthritis (TKA: OR 1.81; THA: OR 
1.84).  
 
Conclusions: There is an increased risk of falls and fractures in early-diagnosed knee and hip 
osteoarthritis compared to those without osteoarthritis. International guidelines on the 
management of hip and knee osteoarthritis should consider the management of falls-risk.  
 
Keywords: Joint degenerative; older people; falls; lower limb; arthritis; injury 
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Introduction 
 
Falls are a serious threat to wellbeing of older people. They are a significant cause of morbidity 
and mortality.1 It has been estimated that approximately 30% of community-dwelling 
individuals aged 65 years and older, and 50% aged 85 years and older, will experience a fall 
annually.2 This can have a number of consequences including fall-related injury with associated 
fractures, reduced confidence and functional independence and ultimately a greater need for 
long-term care.2 Falls-related fracture is considered the most serious of sequaelle.3 Kannegaard 
et al4 estimated that the cumulative mortality among hip fracture patients is 37.1% in men and 
26.4% in women 12 months post-fracture. A number of factors have been associated with 
increased risk of falls. These have included demographic, socio-economic, medical and 
morbidity-related, poly-pharmacy, environmental and physical, including impaired mobility, 
balance and gait problems.5  
 
Osteoarthritis is one of the most common musculoskeletal disorders in the elderly.6 The 
incidence of osteoarthritis is increasing, with the increasing global ageing population, it is 
projected that the prevalence of osteoarthritis will increase from approximately 10% of people 
aged 60 years or older to 40% over the next 20 years.7,8 Osteoarthritis is associated with joint 
pain and stiffness, reduced balance, impeded mobility and loss of functional independence.9 
These factors have all been previously demonstrated to be risk factors for falls in cohorts of 
older people.10,11 
 
Previous studies have demonstrated a link between osteoarthritis of the knee and falls. Doré et 
al11 recently reported the association between the number of lower limb joints affected and falls 
risk, reporting an increased likelihood of falling in symptomatic osteoarthritis cohorts. 
However, previous literature has not examined the risk of subsequent fracture specifically as a 
falls-related injury in a large cohort such as the Osteoarthritis Initiative dataset. This is 
important given that fracture is the most serious consequence of falls associated with mortality 
in older people. It also remains unclear whether falls risk is different for people newly 
diagnosed with hip or knee osteoarthritis, rather than people diagnosed per se, irrespective of 
the duration since diagnosis.  
 
The purpose of this analysis was firstly to determine if there was a difference in the occurrence 
of falls, with or without a consequential fractures, between people newly diagnosed with 
unilateral hip or knee osteoarthritis within the preceding 12 months compared to those who had 
not. Secondly we aimed to explore the risk factors associated with falls and subsequent fracture 
for people with unilateral hip or knee osteoarthritis. Using these findings, it will be possible to 
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better identify when people may be at a greater risk of a fall and falls-related fracture and 
therefore lead to a greater understanding of the relationship between hip and knee osteoarthritis 
and these risks. 
 
Materials and Methods 
 
Data used in the preparation of this article were obtained from the Osteoarthritis Initiative (OAI) 
database, which is available for public access at http://www.oai.ucsf.edu/. The OAI is a large-
scale, multi-centre (four sites across the USA: the Ohio State University; the University of 
Maryland School of Medicine; the University of Pittsburgh and the Memorial Hospital of 
Rhode Island in Pawtucket, Rhode Island), longitudinal cohort study aimed to investigate the 
role of biomarkers in the development and progression of lower limb osteoarthritis. Through 
this, ethical approval has been granted from the Committee on Human Research, University of 
California, San Francisco (IRB approval number 10-00532 Approved 10th March 2015).  
Baseline data collected from volunteers to the study, commenced between February 2004 to 
May 2006, with data longitudinally collected at 12, 24, 30, 36, 48, 60, 72 and 84 months follow-
up intervals. Data collected has included: individual's demographic characteristics, previous 
and current medical history including medical morbidities, lifestyle and physical activity 
behaviours (assessed using the Physical Activity Scale for the Elderly (PASE).12 The minimally 
clinically important difference for the total PASE score is 87 points.13 For this analysis, we 
collated data on: the number of participants who reported a fall within the first 12 months of a 
diagnosis of osteoarthritis; the frequency of falls in this period; and whether a fracture was 
sustained during this period.  
 
To answer this research question, from the OAI dataset, we included all community-dwelling 
people who were diagnosed with unilateral hip or knee osteoarthritis by a medical practitioner 
(clinical with or without radiological evidence) within 12 months of the corresponding data 
collection period. We excluded people who had bilateral hip or knee osteoarthritis, although 
people with unilateral hip and knee osteoarthritis were potentially eligible. A matched-cohort 
was identified of community-dwelling individuals who had not been diagnosed with hip or knee 
osteoarthritis (i.e. had not presented to a physicians with joint pain diagnosed as osteoarthritis) 
from the OAI dataset. The cohorts were matched for: age, ethnicity and PASE score to account 
for the potential confounder of level of participating physical activity.5 There was no overlap 
of patients between these two groups.  
 
Data Analysis 
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Descriptive statistics were initially used to analyse the trends and patterns in categorical and 
continuous data. The normality of the dataset was analysed using the Shapiro-Wilks test. 
 
The aim of the analysis was to determine whether there was a difference in occurrence of falls, 
with or without a consequential fractures, between people newly (within 12 months) diagnosed 
with unilateral hip or knee osteoarthritis, within the preceding 12 months, compared to those 
who had not. To determine this we compared the newly diagnosed unilateral hip or knee 
osteoarthritis cohorts to non-osteoarthritis cohorts using a Student T-Test to assess mean 
cumulative falls, and a chi-square test to assess the occurrence of a fall and the occurrence of a 
fracture in a 12 month period between the groups. We also determine the odds of experiencing 
a fall and fracture in a 12 month period with odd ratios (OR) and 95% confidence intervals (CI) 
for each cohort. 
 
Secondly, we aimed to determine which factors may be associated with the occurrence of a fall 
and/or fracture in people who had been diagnosed with unilateral hip or knee osteoarthritis 
within the preceding 12 months. To determine this, a univariate analysis was initially 
undertaken with the dependent variables: the occurrence of a fall in the preceding 12 months 
and the occurrence of a fracture in the preceding 12 months. The independent variables 
identified through previous research as potential explanatory factors included: age, gender, 
ethnicity, marital status, employment status; previous total hip arthroplasty (THA); previous 
total knee arthroplasty (TKA); diagnosis of hip osteoarthritis; diagnosis of knee osteoarthritis; 
and use of bisphosphonates (assessed as a binary ‘yes/no’ response) in a 12 month interval. 
Based on these, all variables identified as significant at p<0.1 on univariate analysis were 
entered into a multivariate logistical regression model. All logistical regression data was 
expressed as odd ratios with 95% confidence intervals and p-values. The Wald statistic was 
used to assess statistical significance in each regression model. All analyses were undertaken 
using STATA version 12.0 (STATACorp LP, Texas, USA). 
 
Results 
 
As summarised in Figure 1, in total, 552 individual with unilateral hip osteoarthritis were 
compared to 4244 individuals without hip osteoarthritis. Of these 321 (58%) people also had 
unilateral knee osteoarthritis. In the knee osteoarthritis analysis, 1350 individuals with 
unilateral knee osteoarthritis were compared to 3445 individuals without knee osteoarthritis. Of 
these 262 (19%) people also had unilateral hip osteoarthritis. 
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The demographic characteristics of the four groups is presented in Table 1. This demonstrated 
these were broadly similarities in characteristics between the hip analysis group, although there 
was a higher percentage of individuals employed at baseline analysis in the hip osteoarthritis 
compared to the non-hip osteoarthritis cohort (48% versus 60%), and a higher proportion of 
individuals diagnosed with knee osteoarthritis in the hip osteoarthritis group compared to non-
hip osteoarthritis cohort (12% versus 58%). The percentage of individuals prescribed 
bisphosphonate was slightly higher in the non-hip osteoarthritis cohort compared to the hip 
osteoarthritis cohort (87% versus 80%). Similarly, there appeared a slightly greater percentage 
of individuals employed at baseline in the knee osteoarthritis cohort (49%) compared to the 
non-knee osteoarthritis cohort (35%), and a higher percentage diagnosed with hip osteoarthritis 
in the knee osteoarthritis cohort (19%) compared to the non-knee osteoarthritis cohort (1%). 
 
Hip Osteoarthritis Analysis 
 
People with hip osteoarthritis demonstrated a greater likelihood of experiencing a fall within 
the first 12 months post-diagnosis compared to those without hip osteoarthritis  (OR: 1.52; 95% 
CI: 1.26 to 1.84; p<0.01). The chance of experiencing a fall was 52% greater for people with 
hip osteoarthritis compared to those without. Whilst there was a difference in the cumulative 
number of falls within the assessing 12 month period, with significantly greater numbers in the 
hip osteoarthritis cohort (p<0.01), this remained relatively low in each group (0.47 versus 0.66; 
Table 2). 
 
There was a greater likelihood of experiencing a fracture in people who had hip osteoarthritis 
compared to those without (OR: 1.84; 95% CI: 1.23 to 2.75; p<0.01). Thus those with hip 
osteoarthritis demonstrated an 84% greater chance of experiencing a fracture compared to those 
without hip osteoarthritis.  
 
On univariate analysis, the variable bisphosphonate use (OR: 1.30; 95% CI: 1.08 to 1.56), 
physician-diagnosed knee osteoarthritis (OR: 1.20; 95% CI: 1.00 to 0.05) and ethnic 
background (OR: 1.14; 95% CI: 0.96 to 1.37) were identified as significant predictors of falls 
in the first 12 months post-diagnosis of hip osteoarthritis. However, when analysed on 
multivariate analysis, none of these variables remains statistically significant predictors of falls 
(Supplementary Table 1).  
 
When the data were assessed for predictors of fractures, both the use of bisphosphonates (OR: 
2.51; 95% CI: 1.77 to 3.56) and physician-diagnosed knee osteoarthritis (OR: 1.43; 95% CI: 
0.96 to 2.14) were identified as significant predictors. On multivariate analysis, only 
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bisphosphonate use was identified as statistically significant with those taking bisphosphonates 
over twice as likely to have experienced a fracture within the assessing 12 month interval (OR: 
2.27; 95% CI: 1.45 to 3.56). 
 
Knee Osteoarthritis Analysis 
 
People with knee osteoarthritis demonstrated a greater likelihood of experiencing a fall within 
the first 12 months post-diagnosis compared to those without knee osteoarthritis (OR: 1.54; 
95% CI: 1.35 to 1.77; p<0.01). The chances of experiencing a fall were 54% greater for people 
with knee osteoarthritis compared to those without. Whilst a significantly greater cumulative 
number of falls occurred in the knee osteoarthritis cohort (p<0.01; -0.22 to -0.10), this remains 
small compared to the non-knee osteoarthritis cohort (0.45 to 0.61; Table 2). There was also a 
greater likelihood of experiencing a fracture in people newly diagnosed with knee osteoarthritis 
compared to those without (OR: 1.81; 95% CI: 1.34 to 2.43; p<0.01). Thus those with knee 
osteoarthritis were at 81% greater chance of experiencing a fall compared to those without knee 
osteoarthritis. 
 
On univariate analysis, the use of bisphosphonates (OR: 1.32; 95% CI: 1.07 to 1.63), previous 
THA (OR: 2.16; 95% CI: 1.03 to 4.51), contralateral TKA (OR: 0.39; 95% CI: 0.15 to 1.01) 
and hip osteoarthritis (OR: 1.38; 95% CI: 1.07 to 1.77) were identified as significant predictors 
of falls in the first 12 months post-diagnosis of knee osteoarthritis. Of note, the presence of a 
contralateral TKA was associated with a reduction in falls probability by 61%, whereas having 
undergone a THA demonstrated an increased chance of experiencing a fall (OR: 2.16; Table 
3). On multivariate analysis, the variables bisphosphonate use (OR: 1.29; 95% CI: 1.08 to 1.55), 
previous THA (OR: 2.15; 95% CI: 1.03 to 4.49) and physician-diagnosed hip osteoarthritis 
(OR: 1.35; 95% CI: 1.05 to 1.72) remained statistically significant predictors of falls in the 
assessment period.  
 
The variables of bisphosphonate use (OR: 2.37; 95% CI: 1.60 to 3.53) and previous THA (OR: 
3.83; 95% CI: 1.30 to 11.21) were identified as significant predictors of fracture within the first 
12 months post-osteoarthritis diagnosis on univariate analysis. On multivariate analysis, both 
bisphosphonate use (OR: 2.12; 95% CI: 1.47 to 3.04) and previous THA (OR: 3.83; 95% CI: 
1.30 to 11.28) remained statistically significant predictors. People taking bisphosphonates were 
over twice as likely and those who had undergone previous THA were nearly four-times more 
likely to experience fracture during the first 12 months post-diagnosis of knee osteoarthritis. 
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Discussion 
 
People who are newly diagnosed with osteoarthritis of the hip or knee are at greater risk of 
experiencing a fall and/or fracture in the initial 12 months post-diagnosis. The chances of 
experiencing a fall are over 50% greater and the chances of experiencing a fracture are 85% 
greater than people of a similar age and characteristics who do not have hip or knee 
osteoarthritis. Significant predictors of falls in people with knee osteoarthritis include hip 
osteoarthritis, bisphosphonate use and previous THA, with the latter two factors identified as 
significant predictors of fracture. Whilst no statistically significant predictors were identified 
for falls risk in people with hip osteoarthritis, bisphosphonate use was identified as a significant 
predictor of fracture within a 12 month period, although it was unclear whether this was a cause 
or consequence of fracture in people with physician-diagnosed hip osteoarthritis.  
 
The findings of this study support that of previous literature. Doré et al11 reported a similar 
increase in risk of people with osteoarthritis and specifically reported that risk of falling 
increased with the number of painful joints. They reported an increased odds of a fall for those 
with one osteoarthritic joint being 53%, by two joints by 74%, whilst the chances of a fall 
increased to 85% with three or more osteoarthritic joint.11 De Zwart et al14 reported that muscle 
strength was the most significant independent variable associated with falls in people with knee 
osteoarthritis, with factors such as proprioception and joint laxity less significant. These 
findings mirror that of Knoop et al15 analysis of 283 participants from the Amsterdam 
Osteoarthritis cohort. Accordingly the results of Doré et al11 and those of this analysis may be 
related to increased physical risk of experiencing a fall due to reduced hip or/and knee strength 
and proprioception, leading to greater instability and reduced capability to compensate balance 
when made unstable and curtailing of physical activity and independence.16,17  
  
Given the associated risks presented in this analysis, and the high probability that people with 
newly diagnosed osteoarthritis will experience a fall, it would appear sensible that falls advice; 
guidance and training to reduce such risks should be incorporated into early management of 
people with osteoarthritis. Whilst strength and exercise training are advocated in international 
guidance for osteoarthritis,18-21 little attention has been made specifically focusing on falls 
management strategies in this population. This may be particularly important for those with 
greatest pain levels and those with multiple joint pain.11 The results would suggest that this 
should be questioned and future guidance should include recommendations on examining 
individual’s falls risk and intervening where appropriate to mitigate these risks in a tailored, 
individualistic way.22,23 
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Bisphosphonate use was a consistent predictor of falls and fracture risk in both people with hip 
or knee osteoarthritis. This finding should be interpreted with caution. Given the longitudinal 
data collection phases adopted by the OAI programme, it was not possible to distinguish the 
timing of bisphosphonate use in relation to falls or fracture events. Since it is international 
guidance that people at risk of falls with subsequent insufficiency fractures should be routinely 
prescribed some form of bisphosphonate,24,25 it could be interpreted that these cohorts were 
prescribed bisphosphonates following their initial fall within the 12 month follow-up period. 
Thus, this finding is a measurement artefact rather than indicating a causal relationship between 
bisphosphonate use and fracture or falls. In this respect, this finding would suggest that 
guidance, at-least in part, being met where bisphosphonate prescription is being undertaken for 
this ‘at-risk’ subgroup of the osteoarthritis population. Furthermore, since the assessment of 
bisphosphate used was a binary outcome (i.e. yes/no), it is unclear how issues related to 
medication adherence or dosage influenced the outcome of these analyses. This provides further 
strength to the notion that this particular conclusion should be viewed with caution. 
 
This study has indicated that people living in the community, demonstrated a significantly 
higher risk of falls compared to those with similar characteristics without newly diagnosed hip 
or knee osteoarthritis. Nonetheless, the data indicates that falls risk, particularly with older 
people, remains a high problem irrespective of joint pathology. This is in agreement with 
previous literature, particularly in those aged 70 years and above.26 Accordingly, the 
encouragement for older people to be more physically active is supported as a blanket 
recommendation,22,27 not only for the potential risk of falls in osteoarthritic and non-
osteoarthritic cohorts, but also for the more general physical and mental health benefits which 
physical activity confers.28 
 
This analysis presented with five notable limitations, which relate to the use of a large, non-
inception, dataset analysed retrospectively to answer these specific research questions. Firstly, 
it was not possible to determine if there was a difference between osteoarthritis and non-
osteoarthritic cohorts for the type of falls experienced and possible contributing factor to falls. 
Secondly, there was limited data available on the location and type of fracture experienced by 
the cohort, due to a high number of missing data-points. Such an analysis would have provided 
an indication as to whether the types of fractures experienced by the cohort differed, and may 
be a useful addition for future research on this post-surgical population. We were unable to 
analyse the impact of a diagnosis of osteoarthritis on people’s confidence in their mobility. It 
was not possible to observe whether the process of gaining a diagnosis had a significant impact 
on perceived mobility and health. Fourth, we did not intend to assess the relationship of falls in 
this cohort to medical history or co-morbidities. Therefore the contribution of these factors to 
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this analysis has not been established, but may be investigated in future studies. Finally, the 
OAI database is a cohort of volunteers from North America. Whilst this provides valuable data, 
this cohort may be considered a self-selecting sample of potentially healthier and more educated 
or affluent, altruistic individuals compared to the full spectrum of the population in clinical 
practice. This may therefore affect the generalisability of these findings to the wider population 
from different economic, social and cultural backgrounds worldwide. 
 
 
Conclusion 
 
People with newly diagnosed osteoarthritis of the hip or knee have a higher chance of 
experiencing a fall with or without subsequent fracture, compared to those with similar 
characteristics without osteoarthritis. Whilst international guidance on the management of this 
population has emphasised the benefits of exercise and physical activity, consideration should 
now be made to specify recommendations on the identification of those at highest risk of falls 
and interventions to reduce such a risk, and its associated mortality and morbidity.  
 
 
 
Figure and Table Legends 
 
 
Figure 1: Flow-chart illustrating the subject selection based on a priori eligibility criteria. 
 
Table 1: Demographic characteristics  
 
Table 2: Difference between osteoarthritis and non-osteoarthritis participants for falls and 
fracture outcomes over 12 month follow-up 
 
Table 3: Univariate analysis (OR and 95% CI: p-value): factors associated with falls and 
fractures in people who have newly diagnosed hip or knee osteoarthritis, assessed during the 
first 12 months post-diagnosis  
 
Supplementary File 1: Multivariate analysis with probability values and odd ratio; 95% 
confidence intervals (when statistically significant) for predicting falls or fractures in people 
who have newly diagnosed hip or knee osteoarthritis during the first 12 months post-diagnosis, 
when indicated as significant on univariate analysis. 
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Figure 1: Flow-chart illustrating the subject selection based on a priori eligibility criteria. 
 
 
16 
 
Table 1: Demographic characteristics  
 
 Non-Knee OA cohort Knee OA diagnosis Non-Hip OA cohort Hip OA diagnosis 
N 3445 1350 4244 552 
Gender (m/f; %) 1508/1937 
(43.8/56.2) 
534/816 
(39.6/60.4) 
1801/2443 
(42.4/57.6) 
191/361 
(34.6/65.4) 
Mean age in years (SD) 68.9 (8.9) 66.5 (8.8) 69.3 (9.0) 69.4 (9.1) 
Race (n; %) 
1: Other non-white 
2: White or Caucasian 
3: Black or African American 
4: Asian 
 
1: 50 (1.5) 
2: 2758 (80.2) 
3: 599 (17.4) 
4: 34 (0.9) 
 
1: 28 (2.1) 
2: 1023 (75.8) 
3: 286 (21.2) 
4: 13 (0.9) 
 
1: 72 (1.7) 
2: 3372 (79.6) 
3: 756 (17.8) 
4: 38 (0.9) 
 
1: 10 (1.8) 
2: 417 (75.5) 
3: 118 (21.4) 
4: 7 (1.3) 
Marital Status (n; %) 
1: Married 
2: Widowed 
3: Divorced 
4: Separated 
5: Never married 
 
1: 1761 (71.1) 
2: 287 (11.6) 
3: 373 (15.1) 
4: 35 (1.4) 
5: 22 (0.8) 
 
1: 683 (64.2) 
2: 131 (12.3) 
3: 147 (13.8) 
4: 12 (1.1) 
5: 91 (8.6) 
 
1: 2140 (65.2) 
2: 358 (10.9) 
3: 457 (13.9) 
4: 43 (1.3) 
5: 284 (8.7) 
 
1: 272 (63.0) 
2: 61 (14.1) 
3: 50 (11.6) 
4: 4 (0.9) 
5: 45 (10.4) 
Employed (y; %) 1678 (35.0) 657 (48.7) 2040 (48.1) 250 (60.4) 
Number of THA (y; %) 12 (0.3) 20 (1.5) 20 (0.5) 18 (3.3) 
Number of TKA (y; %) 11 (0.3) 29 (2.1) 312 (7.4) 16 (2.9) 
Number of hip OA diagnosed (y; %) 46 (1.3) 262 (19.4) 0 (0.0) 552 (100.0) 
Number of knee OA diagnosed (y; %) 0 (0.0) 1350 (100.0) 498 (11.7) 321 (58.2) 
Bisphosphonates prescribed (y; %) 436 (12.7) 196 (14.5) 498 (11.7) 120 (21.7) 
Mean PASE score (SD) 148 (82.7) 147.6 (81.0) 146.5 (82.7) 137.1 (80.0) 
Type of bisphosphonate prescribed (n; %) 
0: None 
1: Alendronate 
2: Risedronate 
3: Alendronate and Risedronate 
4: Other 
 
0: 2741 (86.3) 
1: 306 (9.6) 
2: 81 (2.6) 
3: 41 (1.3) 
4: 7 (0.2) 
 
0: 1172 (87.1) 
1: 129 (9.6) 
2: 26 (1.9) 
3: 12 (0.9) 
4: 7 (0.5) 
 
0: 3448 (87.4) 
1: 350 (8.9) 
2: 93 (2.4) 
3: 46 (1.2) 
4: 8 (0.1) 
 
0: 443 (80.3) 
1: 79 (14.3) 
2: 17 (3.1) 
3: 8 (1.4) 
4: 5 (0.9) 
 
f – female; m – male; N – number; OA – osteoarthritis; PASE – Physical Activity Scale for the Elderly; SD – standard deviation; THA – total hip arthroplasty; TKA – total 
knee arthroplasty; Y - Yes  
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Table 2: Difference between osteoarthritis and non-osteoarthritis participants for falls and fracture outcomes over 12 month follow-up 
 
 Control Group OA Group 
 
Odd Ratio (95% CI) Difference  
(p-value; 95% CI) 
Hip OA 4244 552   
Fall in past 12 months (Y; %) 1101 (25.9) 192 (34.8) 1.52 (1.26 to 1.84) <0.001 (0.28 to 0.40) 
Fracture in past 12 months (Y; %) 133 (3.1) 31 (5.6) 1.84 (1.23 to 2.75) 0.007 (0.03 to 0.08) 
Mean Cumulative falls in past 12 months (SD) 0.47 (0.84) 0.66 (1.01)  <0.001 (-0.28 to -0.10) 
Knee OA 3445 1350   
Fall in past 12 months (Y; %) 866 (25.1) 461 (34.1) 1.54 (1.35 to 1.77) <0.001 (0.27 to 0.38) 
Fracture in past 12 months (Y; %) 110 (3.2) 76 (5.6) 1.81 (1.34 to 2.43) 0.001 (0.03 to 0.07) 
Mean Cumulative falls in past 12 months (SD) 0.45 (0.82) 0.61 (0.95) N/A <0.001 (-0.22 to -0.10) 
 
CI – confidence interval; N/A – not assessed; OA – osteoarthritis; SD – standard deviation; Y - Yes 
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Table 3: Univariate analysis (OR and 95% CI: p-value): factors associated with falls and fractures in people who have newly diagnosed hip or 
knee osteoarthritis, assessed during the first 12 months post-diagnosis.  
 
 Age Gender Bisphosphonate 
Use 
Marital 
Status 
Employment THR TKR Hip OA Knee OA Race 
Hip OA           
Fall in past 
12 months 
1.00 (0.99, 
1.01) 0.40 
1.04 (0.88, 
1.22) 0.66 
1.30 (1.08, 1.56) 
0.01 
1.02 (0.96, 
1.09) 0.51 
1.00 (0.84, 
1.20) 0.97 
0.57 (0.27, 
1.28) 0.18 
0.69 (0.31, 
1.54) 0.36 
- 1.20 (1.00, 
1.45) 0.05 
1.14 (0.96, 
1.37) 0.15 
Fracture in 
past 12 
months 
1.02 (1.00, 
1.04) 0.12 
0.81 (0.56, 
1.17) 0.26 
 
2.51 (1.77, 3.56) 
<0.01 
1.06 (0.92, 
1.22) 0.44 
0.81 (0.54, 
1.21) 0.31 
0.69 (0.17, 
2.76) 0.60 
0.00 (0.0, 
0.0) 1.00 
- 1.43 (0.96, 
2.14) 0.08 
1.24 (0.83, 
1.86) 0.30 
Knee OA           
Fall in past 
12 months 
1.00 (0.99, 
1.00) 0.97 
1.00 (0.86, 
1.18) 0.91 
 
1.32 (1.07, 1.63) 
0.01 
0.98 (0.92, 
1.05) 0.62 
0.95 (0.80, 
1.14) 0.58 
2.16 (1.03, 
4.51) 0.04 
0.39 (0.15, 
1.01) 0.05 
1.38 (1.07, 
1.77) 0.01 
- 1.06 (0.89, 
1.27) 0.51 
Fracture in 
past 12 
months 
1.00 (0.97, 
1.02) 0.64 
1.04 (0.73, 
1.50) 0.82 
 
2.37 (1.60, 3.53) 
<0.01 
0.98 (0.85, 
1.14) 0.82 
1.01 (0.67, 
1.52) 0.96 
3.83 (1.30, 
11.21) 0.02 
0.67 (0.09, 
5.01) 0.70 
1.23 (0.70, 
2.17) 0.47 
- 0.73 (0.47, 
1.14) 0.16 
 
CI – confidence intervals; OA – osteoarthritis; OR – odd ratio; THA – total hip arthroplasty; TKA – total knee arthroplasty  
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Supplementary File 1: Multivariate analysis with probability values and odd ratio; 95% confidence intervals (when statistically significant) for predicting 
falls or fractures in people who have newly diagnosed hip or knee osteoarthritis during the first 12 months post-diagnosis, when indicated as significant on 
univariate analysis. 
 
 
Hip Osteoarthritis cohort  
 
 Bisphosphonate Use PASE Knee OA Race 
Fall in past 12 months 0.99 0.74 0.99 0.67 
Fracture in past 12 months 2.27 (1.45, 3.56) <0.01 Not eligible 0.33 Not eligible 
 
Knee Osteoarthritis cohort  
 
 Bisphosphonate Use THA TKA Hip OA 
Fall in past 12 months 1.29 (1.08, 1.55) <0.01 2.15 (1.03, 4.49) 0.04 0.06 1.35 (1.05, 1.74) 0.02 
Fracture in past 12 months 2.12 (1.47, 3.04) < 0.01 3.83 (1.30, 11.28) 0.02 Not eligible Not eligible 
 
OA – osteoarthritis; PASE – Physical Activity Scale for the Elderly; THA – total hip arthroplasty; TKA – total knee arthroplasty  
 
